ResearcherSouthwest Medical UniversityActive in the last 2 years
Zhiwei Huang
Matched on ORCID iD 0000-0001-9672-8079; OpenAlex author ID A5071070289. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-κB pathway activation in pancreatitis and pancreatic… Co-author DOI 10.1016/j.cellsig.2024.111033↗
- Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β signal pathway. Co-author DOI 10.1002/ddr.21904↗
- Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective s… Co-author DOI 10.7717/peerj.8811↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenguang Fu · 3 shared papers, 2020–2024 · strength 0.48
- Paper E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-κB pathway a… DOI 10.1016/j.cellsig.2024.111033↗
- Paper Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β sig… DOI 10.1002/ddr.21904↗
- Paper Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic … DOI 10.7717/peerj.8811↗
- Peng Tan · 2 shared papers, 2022–2024 · strength 0.37
- Paper E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-κB pathway a… DOI 10.1016/j.cellsig.2024.111033↗
- Paper Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β sig… DOI 10.1002/ddr.21904↗
- Lingyu Zhao · 1 shared paper, 2024 · strength 0.23
- Hao Chen · 1 shared paper, 2022 · strength 0.15
- Yu Jiang · 1 shared paper, 2020 · strength 0.11
- Ankang Wang · 1 shared paper, 2020 · strength 0.11
- Qiu Li · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.